IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
92.23
+1.92 (2.13%)
Nov 25, 2025, 4:00 PM EST - Market closed
IRADIMED CORPORATION Revenue
IRADIMED CORPORATION had revenue of $21.20M in the quarter ending September 30, 2025, with 15.69% growth. This brings the company's revenue in the last twelve months to $80.51M, up 12.91% year-over-year. In the year 2024, IRADIMED CORPORATION had annual revenue of $73.24M with 11.71% growth.
Revenue (ttm)
$80.51M
Revenue Growth
+12.91%
P/S Ratio
14.56
Revenue / Employee
$503,195
Employees
160
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 73.24M | 7.68M | 11.71% |
| Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
| Dec 31, 2022 | 53.30M | 11.49M | 27.48% |
| Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
| Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IRMD News
- 15 days ago - IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026 - GlobeNewsWire
- 22 days ago - IRADIMED CORPORATION (IRMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025 - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference - GlobeNewsWire
- 3 months ago - IRadimed: Continued Value Unlock With Extensive Reinvestment Runway - Seeking Alpha
- 4 months ago - IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results - GlobeNewsWire